FindTrial
Sign In

Analgesic efficacy of Erector Spinae plane block in thoracolumbar spine surgeries

Analgesic efficacy of Erector Spinae Plane block in thoracolumbar spine surgeries: A randomized controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/04/018395
Enrollment
70
Registered
2019-04-02
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M519- Unspecified thoracic, thoracolumbar and lumbosacral intervertebral disc disorder

Interventions

Intervention1: Erector Spinae Plane block: This block will be administered bilaterally to the allocated patients and 20ml of 0.25% Bupivacaine will be injected on each side Control Intervention1: NIL:

Sponsors

Department of Anaesthesia and Intensive Care
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients undergoing thoracolumbar spine surgeries requiring laminotomy/laminectomy/fusion ASA Grade 1 -2 BMI 18-35

Exclusion criteria

Exclusion criteria: History of relevant drug allergy Coagulopathy History of psychiatric illness/ drug abuse Pregnancy Infection at planned site Chronic analgesic use Psychological inability to understand VAS Inability to operate PCA pump

Design outcomes

Primary

MeasureTime frame
cumulative morphine consumption in the first 24 postoperative hoursTimepoint: 1,2,4,6,8,12,24 hours postoperatively—

Secondary

MeasureTime frame
VAS scores,satisfaction scores,time to first morphine bolus,side effects if any.Timepoint: 1,2,4,6,8,12,24 hours postoperatively.—

Countries

India

Contacts

Public ContactDr Jasveer Singh

GMCH 32

drjassy18@gmail.com9646121664

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026